超声乳化联合房角分离及120°房角切开术治疗晚期原发性闭角型青光眼合并白内障的两年多中心研究结果
多中心前瞻性研究纳入201眼(196例)晚期原发性闭角型青光眼合并白内障患者,行超声乳化人工晶状体植入联合房角分离及120°房角切开术,随访2年。平均眼压从33.0±10.7 mmHg降至13.6±2.9 mmHg,降眼压药物从平均2.4种减至0.4种,完全成功率72.6%(146/201),条件成功率91.5%(184/201)。
要点
- 联合术后2年平均眼压从33.0±10.7 mmHg降至13.6±2.9 mmHg,降眼压药物从2.4种减至0.4种。
- 完全成功率72.6%(146/201),条件成功率91.5%(184/201),仅1眼需行引流管手术。
- 主要并发症为前房积血7.0%(14/201)、眼压骤升4.9%(9/201)、一过性角膜水肿11.4%(23/201)。
核心结论
- 超声乳化人工晶状体植入联合房角分离及120°房角切开术在2年随访中对晚期原发性闭角型青光眼合并白内障显示有效且安全。
- 作者认为该联合手术可作为晚期原发性闭角型青光眼患者的一种替代选择。
研究设计与样本
- 多中心前瞻性研究,纳入196例患者共201眼,均接受超声乳化人工晶状体植入联合房角分离及120°房角切开术。
- 在基线及术后第1天、第7天、1、3、6、12、24个月进行评估,评估眼压、局部降眼压药物种类数、手术并发症及手术成功率。
主要发现
- 平均眼压从33.0±10.7 mmHg降至13.6±2.9 mmHg,局部降眼压药物从平均2.4种降至0.4种(第24个月)。
- 完全成功率72.6%(146/201眼),条件成功率91.5%(184/201眼)。
- 主要并发症为前房积血14眼(7.0%)、眼压骤升9眼(4.9%)、一过性角膜水肿23眼(11.4%)。
- 仅1眼需行引流管手术,无眼发生严重威胁视力的并发症。
- 最佳矫正视力从0.80±1.08 LogMAR提高至0.54±0.78 LogMAR。
临床怎么用
- 作者认为,对于晚期原发性闭角型青光眼合并白内障患者,超声乳化人工晶状体植入联合房角分离及120°房角切开术可考虑作为一种替代选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To report the 2-year effective and safety profile of integrated phacoemulsification with intraocular lens implantation (PEI), goniosynechialysis (GSL) and 120° goniotomy (GT) in advanced primary angle-closure glaucoma (PACG) and cataracts. DESIGN: Multicentre prospective study. METHODS: 201 eyes of 196 patients who received combined PEI+GSL+ GT were assessed at baseline and re-evaluated at days 1, 7, and at 1, 3, 6, 12 and 24 months postsurgery. The intraocular pressure (IOP), the number of topical hypotensive medications, surgical complications and achievements of surgery success were also evaluated. RESULTS: All participants were followed up for a 2-year period. The average IOP declined from 33.0±10.7 mm Hg to 13.6±2.9 mm Hg, and the number of topical hypotensive medication decreased from an average of 2.4 types to 0.4 at month 24. For the safety profile, the major complications were hyphema (n=14, 7.0%), IOP spike (n=9, 4.9%) and transit corneal oedema (n=23, 11.4%). The complete success was achieved in 72.6% of the eyes (146 out of 201), and the qualified success rate was 91.5% (184 out of 201). Only one eye required tube shunt surgery while no one developed severe vision-threatening complications. The best-corrected visual acuity increased from 0.80±1.08 to 0.54±0.78 LogMAR. CONCLUSIONS: PEI+GSL+GT is shown to be effective and safe in treating advanced PACG with cataract over a 2-year follow-up period. The combined surgery may be considered as an alternative for patients with advanced PACG.
引用
- Song Y, Xie L, Zhu X, et al. Two-year outcome of phacogoniotomy for advanced primary angle-closure glaucoma with cataracts: a multicentre study. Br J Ophthalmol. 2025. PMID: 40049755. doi:10.1136/bjo-2024-325375
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。